Is Helicobacter pylori infection in childhood a risk factor for gastric cancer?

PubWeight™: 0.91‹?›

🔗 View Article (PMID 11158472)

Published in Pediatrics on February 01, 2001

Authors

C Imrie1, M Rowland, B Bourke, B Drumm

Author Affiliations

1: Department of Paediatrics, University College Dublin and The Children's Research Centre, Our Lady's Hospital for Sick Children, Dublin, Ireland.

Articles by these authors

Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci (1968) 4.58

Multiple insecticide resistance mechanisms in Anopheles gambiae and Culex quinquefasciatus from Benin, West Africa. Acta Trop (2007) 4.33

Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med (1987) 3.18

Prevalence of myopia in the United States. Arch Ophthalmol (1983) 3.00

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care (1998) 2.97

Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev Sci Tech (2002) 2.76

Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53

Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm (1973) 2.16

Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun (1995) 2.15

Failure of passive zooprophylaxis: cattle ownership in Pakistan is associated with a higher prevalence of malaria. Trans R Soc Trop Med Hyg (1995) 2.11

Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol (1965) 2.11

Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med (1973) 2.11

Application of salivary salicylate data to biopharmaceutical studies of salicylates. J Pharm Sci (1972) 2.10

Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci (1972) 2.08

Influence of route of administration on drug availability. J Pharm Sci (1972) 2.02

Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori. J Pediatr Gastroenterol Nutr (2000) 1.89

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm (1977) 1.87

Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. Br J Clin Pharmacol (1983) 1.86

Concept of a volume of distribution and possible errors in evaluation of this parameter. J Pharm Sci (1968) 1.82

Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology (1997) 1.78

Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77

Anthropometric reference data and prevalence of overweight, United States, 1976-80. Vital Health Stat 11 (1987) 1.76

Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet (1989) 1.72

Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children. J Pediatr (1997) 1.66

The use of population pharmacokinetics in drug development. Clin Pharmacokinet (1996) 1.62

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy (2011) 1.59

Insecticide-treated bednets for the prevention of Plasmodium falciparum malaria in Cambodia: a cluster-randomized trial. Trop Med Int Health (2006) 1.58

Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child (2012) 1.58

A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Trans R Soc Trop Med Hyg (2000) 1.58

Molecular mimicry of ferret gastric epithelial blood group antigen A by Helicobacter mustelae. Gastroenterology (1998) 1.56

Association of symptoms with Helicobacter pylori infection in children. J Pediatr (1995) 1.54

The indoor use of plastic sheeting pre-impregnated with insecticide for control of malaria vectors. Trop Med Int Health (2006) 1.53

Byler-like familial cholestasis in an extended kindred. Arch Dis Child (1996) 1.53

Loss of protection with insecticide-treated nets against pyrethroid-resistant Culex quinquefasciatus mosquitoes once nets become holed: an experimental hut study. Parasit Vectors (2008) 1.53

Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child (2001) 1.52

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions. Clin Pharmacol Ther (2012) 1.51

Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr (1997) 1.50

The oral cavity in Crohn's disease. J Pediatr (2001) 1.44

Helicobacter pylori and sudden-infant-death syndrome. Lancet (2001) 1.42

Chronic varioliform gastritis in childhood. J Pediatr (1989) 1.39

Determination of acetylsalicylic acid and salicylic acid in plasma. J Pharm Sci (1967) 1.38

Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. J Clin Microbiol (1992) 1.33

Campylobacter pyloridis-associated primary gastritis in children. Pediatrics (1987) 1.32

Adherence of Helicobacter pylori to primary human gastrointestinal cells. Infect Immun (1993) 1.32

Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica (1988) 1.30

Insecticide-treated plastic tarpaulins for control of malaria vectors in refugee camps. Med Vet Entomol (2002) 1.29

Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. J Pediatr (2001) 1.29

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther (1995) 1.28

Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Am J Physiol Cell Physiol (2001) 1.26

Intervention epidemiology training: a European perspective. Euro Surveill (2001) 1.25

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Br J Clin Pharmacol (1994) 1.24

An entomological investigation of the likely impact of cattle ownership on malaria in an Afghan refugee camp in the North West Frontier Province of Pakistan. Med Vet Entomol (1994) 1.24

Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. J Pharm Sci (1984) 1.22

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model. Clin Pharmacol Ther (1994) 1.21

Control of zoophilic malaria vectors by applying pyrethroid insecticides to cattle. Trop Med Int Health (1999) 1.19

Determination of lidocaine in blood and tissues. Anesthesiology (1973) 1.19

Disposition kinetics of lidocaine in normal subjects. Ann N Y Acad Sci (1971) 1.16

Chlorfenapyr: a pyrrole insecticide for the control of pyrethroid or DDT resistant Anopheles gambiae (Diptera: Culicidae) mosquitoes. Acta Trop (2007) 1.15

The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Am Heart J (1971) 1.13

Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics. Fertil Steril (1994) 1.13

Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil Steril (1994) 1.13

Acute cytomegalovirus infection in a child with Ménétrier's disease. Gastroenterology (1995) 1.12

Influence of congestive heart failure on blood vessels of lidocaine and its active monodeethylated metabolite. Clin Pharmacol Ther (1975) 1.12

Determination of tolbutamide and chlorpropamide in biological fluids. J Pharm Pharmacol (1973) 1.12

Adherence of Helicobacter pylori to human gastric epithelial cells in vitro. J Med Microbiol (1991) 1.11

Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol (1989) 1.11

Distribution and spread of pyrethroid and DDT resistance among the Anopheles gambiae complex in Tanzania. Med Vet Entomol (2013) 1.10

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. Pharm Res (2000) 1.09

Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools. J Clin Microbiol (2001) 1.09

Application of salivary concentration data to pharmacokinetic studies with antipyrine. J Pharm Sci (1977) 1.09

Low rates of Helicobacter pylori reinfection in children. Gastroenterology (1999) 1.08

High altitude epidemic malaria in Bamian province, central Afghanistan. East Mediterr Health J (2003) 1.08

Plasma protein binding and therapeutic drug monitoring. Ther Drug Monit (1980) 1.07

Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther (2001) 1.06

Health care under the Taliban. Lancet (1997) 1.06

Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients. Br J Clin Pharmacol (1987) 1.05

Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur J Clin Pharmacol (1987) 1.05

Experimental hut evaluation of the pyrrole insecticide chlorfenapyr on bed nets for the control of Anopheles arabiensis and Culex quinquefasciatus. Trop Med Int Health (2008) 1.05

Protein binding and drug clearance. Clin Pharmacokinet (1984) 1.05

Routine mobilization of the splenic flexure is not necessary during anterior resection for rectal cancer. Dis Colon Rectum (2007) 1.04

Tissue water content in rats measured by desiccation. J Pharmacol Toxicol Methods (1997) 1.04

Fatal marrow aplasia in patient on penicillamine. Lancet (1976) 1.04

External counting and scintiphotography in rabbits with arthritis. Arthritis Rheum (1969) 1.04

Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Ann Trop Med Parasitol (1997) 1.04

The role of physiologically based pharmacokinetic modeling in regulatory review. Clin Pharmacol Ther (2012) 1.04

Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol (2001) 1.04

Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther (1998) 1.03

Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clin Pharmacol Ther (1974) 1.03

Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med (1985) 1.02

Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects. Clin Pharmacol Ther (1987) 1.02

Disposition kinetics of quinidine. Clin Pharmacol Ther (1976) 1.02

Griseofulvin-phenobarbital interaction in man. JAMA (1970) 1.01

Absorption of prednisolone in patients with Crohn's disease. Gut (1983) 1.01

Comparison of three pyrethroid treatments of top-sheets for malaria control in emergencies: entomological and user acceptance studies in an Afghan refugee camp in Pakistan. Med Vet Entomol (2002) 1.00

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. J Clin Pharmacol (2000) 1.00

Blood pressure levels and hypertension in persons ages 6-74 years: United States, 1976-80. Adv Data (1982) 1.00

Urinary excretion of methylamphetamine in man. Nature (1965) 1.00